These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 4607442)
1. Some recent advances in the study of microtubules and microtubule poisons. Dustin P Arch Biol (Liege); 1974; 85(2):263-88. PubMed ID: 4607442 [No Abstract] [Full Text] [Related]
2. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class. Owellen RJ; Hartke CA; Dickerson RM; Hains FO Cancer Res; 1976 Apr; 36(4):1499-502. PubMed ID: 1260766 [TBL] [Abstract][Full Text] [Related]
3. A possible role of microtubules in catecholamine release from the adrenal medulla: effect of colchicine, vinca alkaloids and deuterium oxide. Poisner AM; Bernstein J J Pharmacol Exp Ther; 1971 Apr; 177(1):102-8. PubMed ID: 5566754 [No Abstract] [Full Text] [Related]
4. Action of drugs on microtubules. Wilson L Life Sci; 1975 Aug; 17(3):303-9. PubMed ID: 1099380 [No Abstract] [Full Text] [Related]
5. Interaction of drugs with microtubule proteins. Wilson L; Bamburg JR; Mizel SB; Grisham LM; Creswell KM Fed Proc; 1974 Feb; 33(2):158-66. PubMed ID: 4855812 [No Abstract] [Full Text] [Related]
11. In situ response to vinka alkaloids by microtubules in cultured post-implanted mouse embryos. Meininger V; Binet S; Chaineau E; Fellous A Biol Cell; 1990; 68(1):21-9. PubMed ID: 2180513 [TBL] [Abstract][Full Text] [Related]
12. Effects of microtubular inhibitors on plasma membrane calmodulin-dependent Ca2+-transport ATPase. Gietzen K; Wüthrich A; Bader H Mol Pharmacol; 1982 Sep; 22(2):413-20. PubMed ID: 6216398 [No Abstract] [Full Text] [Related]
13. Inhibition of microtubule formation by uremic toxins: action mechanism and hypothesis about the active component. Braguer D; Gallice P; Monti JP; Murisasco A; Crevat A Clin Nephrol; 1986 Apr; 25(4):212-8. PubMed ID: 3698354 [TBL] [Abstract][Full Text] [Related]
14. [Microtubules and microfilaments: their role in cellular dynamics]. Dustin P Arch Biol (Liege); 1972; 83(3):419-80. PubMed ID: 4665072 [No Abstract] [Full Text] [Related]
15. Microtubules as drug receptors: pharmacological properties of microtubule protein. Wilson L Ann N Y Acad Sci; 1975 Jun; 253():213-31. PubMed ID: 1096718 [No Abstract] [Full Text] [Related]
16. Mitosis inhibitors and axonal transport. Hanson M; Edström A Int Rev Cytol Suppl; 1978; (7):373-402. PubMed ID: 79566 [No Abstract] [Full Text] [Related]
17. A new culture model facilitating rapid quantitative testing of mitotic spindle inhibition in mammalian cells. De Brabander M; Van de Veire R; Aerts F; Geuens S; Hoebeke J J Natl Cancer Inst; 1976 Feb; 56(2):357-63. PubMed ID: 1255766 [TBL] [Abstract][Full Text] [Related]
18. [Biological characteristics of microtubule and related drug research]. Li JN; Jiang JD Yao Xue Xue Bao; 2003 Apr; 38(4):311-5. PubMed ID: 12889136 [No Abstract] [Full Text] [Related]
19. Colchicine-sensitive microtubules. Margulis L Int Rev Cytol; 1973; 34():333-61. PubMed ID: 4267164 [No Abstract] [Full Text] [Related]
20. Rhazinilam mimics the cellular effects of taxol by different mechanisms of action. David B; Sévenet T; Morgat M; Guénard G; Moisand A; Tollon Y; Thoison O; Wright M Cell Motil Cytoskeleton; 1994; 28(4):317-26. PubMed ID: 7954858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]